The aim of this study was to retrospectively investigate the effects of sugammadex or neostigmine, which are routinely used after the completion of surgery to antagonize (reverse) neuromuscular blockade in adult patients undergoing cranial surgery under general anesthesia, on early extubation in the operating room, intensive care unit admission and length of stay, length of hospital stay, and hospital costs.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The amount of cost in the hospital process
Timeframe: through study completion, an average of 3 month
Length of stay in the intensive care unit
Timeframe: through study completion, an average of 3 month
Early extubation rate after two different neuromuscular blocking antagonist drugs
Timeframe: through study completion, an average of 3 month